about
Pathophysiology of age-related diseasesOsteoporosis, inflammation and ageingThe immune system in the elderly: II. Specific cellular immunity.An update on autoinflammatory diseasesIncreased levels of interleukin 31 (IL-31) in osteoporosis.Inflammation markers predicting frailty and mortality in the elderly.Senile osteoporosis: is it an immune-mediated disease?Apoptosis remodeling in immunosenescence: implications for strategies to delay ageing.Osteoimmunology and Beyond.Allergy and Aging: An Old/New Emerging Health IssueAn overview of environmental risk factors in systemic sclerosis.17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines.Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer.7-ketocholesterol and 5,6-secosterol modulate differently the stress-activated mitogen-activated protein kinases (MAPKs) in liver cells.[Hyperbaric oxygen therapy and respiratory function]The impact of HIV infection on lactose absorptive capacity.Dipeptidyl amino peptidase IV cytochemistry in circulating lymphocytes from HIV-I-seropositive subjects.Raynaud's phenomenon and nailfold capillaroscopic findings in anorexia nervosa.Effect of zinc ions on apoptosis in PBMCs from healthy aged subjects.Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans.Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity.CD50 and CD62L adhesion receptor expression on naive (CD45RA+) and memory (CD45RO+) T lymphocytes in the elderly.Immunophenotypical changes of T lymphocytes in the elderly.Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection.Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report.7-Ketocholesterol and 5,6-Secosterol Modulate Differently the Stress-Activated Mitogen-Activated Protein Kinases (MAPKs) in Liver CellsInterleukin-33 serum levels in postmenopausal women with osteoporosisExercise-induced variations of lymphocytosis in the lymphoproliferative disease of large granular lymphocytes[Epidemiologic and clinical study of HIV in jails: personal experience]Tuftsin deficiency in AIDSHowell-Jolly body counting as a measure of splenic function. A reassessmentRecurrence of Hodgkin's disease after a 28-year disease-free interval. A case reportSelective involvement of monocytes by acquired myeloperoxidase deficiency in a case of chronic myelomonocytic leukemiaDifferential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometryAutologous bone marrow transplantation for uterine sarcoma. Case reportEpididymal lymphoma. A case report[Extranodal localizations of lymphoma. Clinico-epidemiologic study of 353 cases]Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly[Clinical uses of flow cytometry in hematological oncology]Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry
P50
Q21245033-F8B44015-D8F5-4D94-8B18-48124659285AQ24815520-057EF7A4-EA0D-49EF-AA3D-389B0181A6BDQ33784049-232F009E-90D5-4129-8A35-0E1A0D2E6069Q34380526-BBB6D815-0BAE-4536-80CE-739E0817938EQ36142219-920A21CC-6A70-4C9E-B7C6-850B3D047B42Q36388062-825B3F40-6ECA-4C4C-BE56-B9E194BA60C8Q36654951-9E02B044-D668-4E11-8089-7D0443D2EB21Q36855409-70A7E286-E97F-4471-A2A8-16A9717AA8CDQ37548012-50670B72-D553-4F5C-AF63-5043218D0683Q37716135-30690EA1-63C1-48F2-A41B-B255276800EDQ38648592-7F89D866-5B08-48D5-B4E6-63480B4D8D8CQ38706293-049E1034-BCF0-40E3-92CB-B7A334D50472Q40650864-A35CD42D-7F45-4AB2-B578-54900100BE52Q43235908-808CD854-F50E-46A3-A90E-9F36248F0EC5Q43408435-FEAC5A04-B995-4706-ABA3-45EAAD2A4073Q44480668-2E86E9A3-CADC-4728-8767-DF29661DA89FQ45659432-5C58B902-89E7-4A4B-9F0A-7048BBD8412DQ48324745-914D09B2-49C2-4912-8409-782DE51C8B0EQ51978702-4C39536E-BAA2-4142-90EC-FDF1140EF786Q51984336-EF1F4A5B-38EA-4061-BE6A-873D4F16CDDEQ51993068-1828E500-E497-4665-A6B3-F3234CF64C89Q52018222-E061FC48-D4EE-4474-B315-F16119570BE6Q52024868-70034FAC-5888-4A7E-A8B9-9201AE4FEA29Q52044787-B40E49F5-A5E7-49CB-BF25-02483845720AQ55438683-F6F0BCD2-382D-49D0-AC54-4149D60090CEQ56913156-48B431D5-FE8B-4824-8712-3EA5F294B0D8Q64123640-D7AF596F-AAAD-406C-9944-248C84BA2D70Q67570583-6216B64F-B572-4378-9485-CF95C76AB673Q68122124-9F641104-A36E-4092-B434-BB844EB1A69EQ68289623-4F67FAB1-B533-4CDD-89DC-6962C0FA2B73Q68373505-BCF67FF9-DB65-456C-8967-FF4F085BE843Q69434565-C0FD9E2E-1D8A-4E1D-9DD1-58FBF80CA13AQ70458932-00444F0F-3F18-43FE-9A92-80EE0B77D864Q71248580-4009F984-6C8A-4A5D-93A5-9F90EB61ECCBQ71550168-2CFA5E62-4294-47DF-B471-440B46DA7665Q72869378-9183C6B3-DEED-4009-B942-7C9D36A3D7E1Q73175512-A4B8D070-1588-4679-B333-7CEB71484DDCQ73470876-B26972D3-9D4A-4D4C-8AA9-2397D0A4D896Q73474883-57A9F876-CC74-41C0-BCFC-3A2977AE3E2FQ73835901-11D68657-8470-4FF6-A083-AF8D416A631F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lia Ginaldi
@ast
Lia Ginaldi
@en
Lia Ginaldi
@es
Lia Ginaldi
@nl
Lia Ginaldi
@sl
type
label
Lia Ginaldi
@ast
Lia Ginaldi
@en
Lia Ginaldi
@es
Lia Ginaldi
@nl
Lia Ginaldi
@sl
prefLabel
Lia Ginaldi
@ast
Lia Ginaldi
@en
Lia Ginaldi
@es
Lia Ginaldi
@nl
Lia Ginaldi
@sl
P106
P1153
56021643400
P21
P31
P496
0000-0003-1841-2807